Tianjin Pharmaceutical Da Ren Tang announces HY2026 interim results release for six months ended June 30, 2026

PUBT · 3d ago
Tianjin Pharmaceutical Da Ren Tang announces HY2026 interim results release for six months ended June 30, 2026
  • Tianjin Pharmaceutical Da Ren Tang published an announcement on an online investor conference covering HY2026 results for the six months ended June 30, 2026.
  • The remote session is scheduled for Sept. 3, 2026, 3:00 p.m.–5:00 p.m., hosted on 全景路演 at http://rs.p5w.net.
  • The interim results were released on Aug. 14, 2026, with the HY2026 results announcement posted on https://www.sgx.com/.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin Pharmaceutical Da Ren Tang Group Corporation Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: QP0VGZTAEYC0QRSQ) on August 26, 2026, and is solely responsible for the information contained therein.